Analysis
While Anthropic's reported $2 trillion IPO target dominates this week's public-markets headlines, the SEC's routine S-1 pipeline kept moving on smaller offerings, based on filings reviewed via SEC EDGAR:
- SharonAI Holdings Inc. — filed an S-1 on August 12 covering 8,021,282 shares of Class A common stock for a Nasdaq Capital Market listing.
- BirchBioMed Inc. — a clinical-stage biopharmaceutical company developing therapies for scarring, fibrosis and certain autoimmune diseases, filed to pursue a Nasdaq Global Market direct listing under ticker BRBM, registering up to 29,925,851 existing shares for resale.
- Fast Finance Pay Corp. — a New York-based Nevada corporation, filed its S-1 on August 12.
- Onconetix, Inc. — filed to register up to 100,000,000 shares of common stock for resale by existing selling stockholders.
- American Battery Materials Inc. — an exploration-stage critical-minerals company developing direct lithium extraction in Utah's Paradox Basin, filed an amended S-1 for a primary offering of roughly 3,327,273 shares and warrants at an assumed $5.50 price, alongside pre-funded warrants.
- Karman Line Acquisition Corp. — a special-purpose acquisition company, also has an active registration in the current filing cycle, per SEC filing indices.
Why This Matters Next to a $2 Trillion Headline
Most of these filings are resale registrations or small primary offerings, not new operating companies debuting at scale -- Onconetix and BirchBioMed's filings largely register existing shareholders' stock for resale rather than raising fresh primary capital, and American Battery Materials' roughly $18 million implied raise is a rounding error next to Anthropic's reported ambitions. That gap illustrates the two-tier structure of the current IPO market: a handful of AI mega-caps commanding trillion-dollar attention, and a much larger, quieter volume of small-cap and micro-cap filings that make up the actual bulk of SEC listing activity in any given week.
The Counterweight
Small-cap S-1 filings, particularly resale registrations, carry meaningfully higher volatility and lower institutional coverage than mega-cap IPOs, and several of this week's filers -- Onconetix among them -- have filed multiple amended S-1s in past cycles, a pattern that can indicate an offering struggling to find its final terms rather than a clean path to listing.
